Maryland MPJE EXAM 2026-2027 LATEST
VERSION QUESTIONS AND VERIFIED CORRECT
ANSWERS JUST RELEASED
A pharmacist shall not be required to counsel a patient or care giver when the patient or
care giver refuses such consultation, and such refusal is documented.
A. True
B. False - answer>>>a. True
Which of the following is/are TRUE about refilling a prescription drug or device when the
pharmacist fails to obtain authorization from the prescriber?
I. A pharmacist can fill the prescription drug or device if he thinks that the drug or device
is required for continuation of therapy for chronic conditions.
II. A pharmacist can fill the prescription drug or device if he thinks that the interruption of
the therapy may produce serious health consequences.
III. A pharmacist can fill the prescription drug if the refill of the prescription is not for a
controlled substance. - answer>>>I, II, and III.....the RPh:
(i). Enters on the back of the prescription or on another appropriate uniformly
maintained, readily retrievable record, such as a medication record, the date and the
quantity of the drug or device dispensed; and
(ii). Signs or initials the record.
The pharmacist notifies the authorized prescriber of the refill of the prescription within 72
hours of dispensing the drug or device.
If a pharmacist refills a prescription under subsection (a) of this section, the pharmacist
may provide only 1 refill of the prescription and the refill quantity dispensed shall be in
conformity with the prescriber's directions for use and may not exceed a 14-day supply or
unit of use.
, -
A pharmacist has substituted generic Metoprolol (Mfg: Mylan) for the prescribed brand
name Lopressor (Mfg: Pfizer). Which of the following shall be placed on the dispensing
label?
A. Metoprolol, (Mylan)
B. Metoprolol, Lopressor (Mylan)
C. Metoprolol, (a generic for Lopressor)
D. Lopressor (Pfizer), Metoprolol - answer>>>B. Metoprolol, Lopressor (Mylan)
If, under the section 12-504, the pharmacist substitutes a drug or device product for that
named by the authorized prescriber, the label shall indicate both the name of the drug or
device product and the name of the manufacturer or distributor of the drug or device
dispensed.
A pharmacist shall inform a retail consumer to the best of the pharmacist's knowledge of
the availability of a generically equivalent drug every time he/she dispenses a prescription
EXCEPT:
I. If a prescription is written for a generic drug.
II. When the authorized prescriber states expressly that the prescription is to be
dispensed only as directed.
III. When the cost of the prescription is reimbursed by a third party payer, including
medical assistance. - answer>>>I, II, and III
A pharmacist from a primary pharmacy may permanently transfer a prescription order to
a secondary pharmacy to be dispensed to a specific patient if:
I. The prescription is for a Schedule II controlled dangerous substance.
II. The prescription is for a Schedule III controlled dangerous substance.
III. The prescription is for a Schedule IV controlled dangerous substance. - answer>>>II
and III only......RPh must indicate:
, (1). That the prescription has been permanently transferred;
(2). The name of the secondary pharmacy;
(3). The name of the pharmacist who transferred the prescription to the secondary
pharmacy;
(4). The name of the pharmacist at the secondary pharmacy to whom the prescription
was transferred if the transfer occurred in an oral manner; and
(5). The date on which the prescription was transferred to the secondary pharmacy.
A. A pharmacist at the primary pharmacy may not refill a prescription that has been
permanently transferred to a secondary pharmacy.
B. The use of unified prescription records by more than one pharmacy through a
computerized prescription database does not constitute a permanent transfer of a
prescription order.
Which of the following is/are classified as Schedule IV controlled drug(s)?
I. Oxazepam
II. Zaleplon
III. Butorphanol - answer>>>I, II, and III....Schedule IV:
Tramadol, Carisoprodol, Alprazolam, Barbital, Butorphanol, Chloral hydrate,
Chlordiazepoxide, Clonazepam, Clorazepate, Dexfenfluramine, Diazepam,
Dichloralphenazone, Difenoxin 1 mg/ Atropine 25 mcg, Estazolam, Ethchlorvynol,
Fenfluramine, Flurazepam, Fospropofol,** Lorcaserin, Lorazepam, Mazindol,
Meprobamate, Midazolam, Modafinil, Oxazepam, Pemoline, Pentazocine, Phenobarbital,
Phentermine**, Phentermine + Topiramate, Prazepam, Propofol, Propoxyphene dosage
forms with other ingredients, Quazepam, Sibutramine**, Solriamfetol**, Suvorexant,
Temazepam, Triazolam, Zaleplon, Zolpidem, Zopiclone, Eszopiclone
If the federal or State government declares a state of emergency, a pharmacist working in
the area declared an emergency may refill a prescription for a drug for which the refill has
not been authorized if:
I. The refill of the prescription is not for a controlled dangerous substance.
II. The quantity dispensed does not exceed a 14-day supply or unit of use.
VERSION QUESTIONS AND VERIFIED CORRECT
ANSWERS JUST RELEASED
A pharmacist shall not be required to counsel a patient or care giver when the patient or
care giver refuses such consultation, and such refusal is documented.
A. True
B. False - answer>>>a. True
Which of the following is/are TRUE about refilling a prescription drug or device when the
pharmacist fails to obtain authorization from the prescriber?
I. A pharmacist can fill the prescription drug or device if he thinks that the drug or device
is required for continuation of therapy for chronic conditions.
II. A pharmacist can fill the prescription drug or device if he thinks that the interruption of
the therapy may produce serious health consequences.
III. A pharmacist can fill the prescription drug if the refill of the prescription is not for a
controlled substance. - answer>>>I, II, and III.....the RPh:
(i). Enters on the back of the prescription or on another appropriate uniformly
maintained, readily retrievable record, such as a medication record, the date and the
quantity of the drug or device dispensed; and
(ii). Signs or initials the record.
The pharmacist notifies the authorized prescriber of the refill of the prescription within 72
hours of dispensing the drug or device.
If a pharmacist refills a prescription under subsection (a) of this section, the pharmacist
may provide only 1 refill of the prescription and the refill quantity dispensed shall be in
conformity with the prescriber's directions for use and may not exceed a 14-day supply or
unit of use.
, -
A pharmacist has substituted generic Metoprolol (Mfg: Mylan) for the prescribed brand
name Lopressor (Mfg: Pfizer). Which of the following shall be placed on the dispensing
label?
A. Metoprolol, (Mylan)
B. Metoprolol, Lopressor (Mylan)
C. Metoprolol, (a generic for Lopressor)
D. Lopressor (Pfizer), Metoprolol - answer>>>B. Metoprolol, Lopressor (Mylan)
If, under the section 12-504, the pharmacist substitutes a drug or device product for that
named by the authorized prescriber, the label shall indicate both the name of the drug or
device product and the name of the manufacturer or distributor of the drug or device
dispensed.
A pharmacist shall inform a retail consumer to the best of the pharmacist's knowledge of
the availability of a generically equivalent drug every time he/she dispenses a prescription
EXCEPT:
I. If a prescription is written for a generic drug.
II. When the authorized prescriber states expressly that the prescription is to be
dispensed only as directed.
III. When the cost of the prescription is reimbursed by a third party payer, including
medical assistance. - answer>>>I, II, and III
A pharmacist from a primary pharmacy may permanently transfer a prescription order to
a secondary pharmacy to be dispensed to a specific patient if:
I. The prescription is for a Schedule II controlled dangerous substance.
II. The prescription is for a Schedule III controlled dangerous substance.
III. The prescription is for a Schedule IV controlled dangerous substance. - answer>>>II
and III only......RPh must indicate:
, (1). That the prescription has been permanently transferred;
(2). The name of the secondary pharmacy;
(3). The name of the pharmacist who transferred the prescription to the secondary
pharmacy;
(4). The name of the pharmacist at the secondary pharmacy to whom the prescription
was transferred if the transfer occurred in an oral manner; and
(5). The date on which the prescription was transferred to the secondary pharmacy.
A. A pharmacist at the primary pharmacy may not refill a prescription that has been
permanently transferred to a secondary pharmacy.
B. The use of unified prescription records by more than one pharmacy through a
computerized prescription database does not constitute a permanent transfer of a
prescription order.
Which of the following is/are classified as Schedule IV controlled drug(s)?
I. Oxazepam
II. Zaleplon
III. Butorphanol - answer>>>I, II, and III....Schedule IV:
Tramadol, Carisoprodol, Alprazolam, Barbital, Butorphanol, Chloral hydrate,
Chlordiazepoxide, Clonazepam, Clorazepate, Dexfenfluramine, Diazepam,
Dichloralphenazone, Difenoxin 1 mg/ Atropine 25 mcg, Estazolam, Ethchlorvynol,
Fenfluramine, Flurazepam, Fospropofol,** Lorcaserin, Lorazepam, Mazindol,
Meprobamate, Midazolam, Modafinil, Oxazepam, Pemoline, Pentazocine, Phenobarbital,
Phentermine**, Phentermine + Topiramate, Prazepam, Propofol, Propoxyphene dosage
forms with other ingredients, Quazepam, Sibutramine**, Solriamfetol**, Suvorexant,
Temazepam, Triazolam, Zaleplon, Zolpidem, Zopiclone, Eszopiclone
If the federal or State government declares a state of emergency, a pharmacist working in
the area declared an emergency may refill a prescription for a drug for which the refill has
not been authorized if:
I. The refill of the prescription is not for a controlled dangerous substance.
II. The quantity dispensed does not exceed a 14-day supply or unit of use.
